News

Applied Clinical Trials Online1d
Gilead’s Trodelvy Meets Primary Endpoint of Progression-Free Survival in Phase III ASCENT-03 Breast Cancer Study
In patients with first-line metastatic triple-negative breast cancer who are not candidates for PD-1/PD-L1 inhibitors, ...
Applied Clinical Trials Online2d
New Phase III Data Show Bayer’s Nubeqa Significantly Improves Quality of Life for Prostate Cancer Patients
In a post-hoc analysis from the Phase III ARANOTE trial, new results show metastatic castration-sensitive prostate cancer ...
Applied Clinical Trials Online1d
Clinical Trial Monitoring: Should Randomization Be Included?
Randomization monitoring is a type of statistical/central monitoring, which ICH notes should be performed by appropriately qualified/trained individuals, (e.g., biostatisticians). 4 Thus, ...
Applied Clinical Trials Online6d
ARCHES and ENZAMET Trials Confirm Long-Term Xtandi Efficacy in Metastatic Hormone-Sensitive Prostate Cancer
Five- and eight-year trial data to be presented at ASCO demonstrate durable survival outcomes with Xtandi (enzalutamide) plus ...
Applied Clinical Trials Online2d
The Future of Drug Discovery: AI-Powered Predictions and Virtual Patient Models
In this video interview, Michel van Harten, MD, CEO, myTomorrows, highlights the potential of artificial intelligence in digital twin technology.
Applied Clinical Trials Online6d
How AI Lowers the Real-World Barriers to Trial Participation
In this video interview, Michel van Harten, MD, CEO, myTomorrows, discusses how patient education and remote monitoring can help with reducing the burden of trial participation.
Applied Clinical Trials Online9h
Future Proofing Your Outsourcing Strategy: How to Stay Agile in a Fast-Moving Clinical Trial Ecosystem
A blend of FSO and FSP models in the landscape of artificial intelligence can ensure CROs stay up to date with the unique ...